InvestSMART

PainChek Ltd (ASX:PCK)

ALERT: Price-sensitive ASX Announcement for PCK
Current share price for PCK : $0.096 -0.004 (-4%)+
Announcement
Release
22 Jul 2026 8:29AM
Price at Release
$0.100
Full Release
download
Summary
PainChek Ltd announced the receipt of a $1.123 million R&D tax incentive refund for the 2025 financial year. This refund strengthens the company's cash position and supports ongoing investment in developing and commercializing their AI-powered pain assessment applications. The refund is attributed to the eligible R&D expenditures, including the development of the PainChek Adult and Infant algorithms and activities aiding the entry into the US market. The R&D Tax Incentive is an Australian government program providing eligible companies with a cash offset of up to 43.5% of qualifying R&D expenditure.
Key Points
  • $1.123 million R&D tax incentive refund received by PainChek Ltd.
  • The refund relates to eligible FY2025 R&D expenditures.
  • Development of PainChek Adult and Infant algorithms included in the R&D activities.
  • The refund supports PainChek's cash position and further product development.
  • The R&D Tax Incentive is an Australian Government program offering a cash offset.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.